Senior Clubfoot Advisor, CURE Clubfoot / Clubfoot
Chris Lavy is Professor of Orthopaedic and Tropical Surgery at the University of Oxford, England, and also Honorary Professor at the London School of Hygiene and Tropical Medicine. He is a fellow of Green Templeton College, Oxford, and a trustee and council member of the Royal College of Surgeons of England.
Chris was trained at University College London and St Bartholomew’s Hospital Medical College, with further training at the Royal National Orthopaedic Hospital and in Oxford, Norwich, Bath, Paris, and Cape Town.
His first consultant post was at the Middlesex Hospital in London, but in 1996 he moved to Malawi to work with Christoffel-Blindenmission (CBM). He has worked for over 12 years in Africa. Chris was instrumental in developing the vision and raising funds for the construction of CURE Malawi and CURE Zambia. Chris currently serves as the Senior Clubfoot Advisor for CURE Clubfoot.
Chris is committed to surgical training and research in sub-Saharan Africa. He was a founding council member of the College of Surgeons of East, Central, and Southern Africa (COSECSA) in 1999, and continues this work with the COOL project (COSECSA Oxford Orthopaedic Link). He is a commissioner for the Lancet Commission on Global Surgery.
Chris holds BSc, MBBS, and MD degrees from the University of London, an MCh from the University of Liverpool, and fellowships in surgery from COSECSA and the Royal College of Surgeons of England. He was awarded an OBE by the Queen in 2007 for services to international orthopaedics.
Senior Medical Director, CURE Hydrocephalus / Hydrocephalus & Spina Bifida
Benjamin Warf is a pediatric neurosurgeon who has revolutionized the treatment of intra-cranial diseases in very young children, with a particular focus on hydrocephalus (“water on the brain”). Many children with untreated hydrocephalus do not survive or suffer significant cognitive disabilities; such outcomes are common in parts of the world where access to neurosurgery is scarce. In 2000, Warf became Medical Director and Chief of Surgery at the newly established CURE Children’s Hospital in Mbale, Uganda, where he encountered a high incidence of hydrocephalus.
Because traditional treatment of hydrocephalus—insertion of shunts—is both prohibitively expensive and requires sustained medical monitoring beyond the reach of most children in the developing world, Warf introduced an alternative, low-cost treatment. In carefully designed clinical trials, he demonstrated that a relatively straightforward, one-time treatment using modern endoscopic techniques (based on a surgical approach first attempted in the early twentieth century) results in outcomes that are at least as safe and effective as ventricular shunts, but requires far less medical infrastructure and post-surgical maintenance. As an adjunct to his clinical practice, Warf developed CURE Hydrocephalus & Spina Bifida, a training program and network for neurosurgeons throughout Africa, Asia, and the Middle East, increasing exponentially the number of children who can now be treated using his method. He has returned to practicing pediatric neurosurgery in the United States, and is now working to expand worldwide knowledge of and access to hydrocephalus treatment he pioneered.
Benjamin Warf received a B.S. (1980) from Georgetown College and an M.D. (1984) from Harvard Medical School. He completed his residency (1985–1991) in neurosurgery at Case Western Reserve University. From 2000 to 2006, he served as medical director and chief of surgery at CURE Children’s Hospital of Uganda, and in 2010 he joined the faculty of Harvard Medical School, where he is currently a professor of neurosurgery. He is also the Hydrocephalus and Spina Bifida Chair at Boston Children’s Hospital. Dr. Warf serves as Senior Medical Director of CURE Hydrocephalus & Spina Bifida and was named a MacArthur Fellow in 2012. His prior affiliations include the University of Kentucky (1992–2000) and Thomas Jefferson University (2007–2009).